신규 스트렙토코커스 균주 및 상기 신규 스트렙토코커스 균주와 몬타나이드 보조제를 이용한 어류의 세균성 질병 예방용 혼합 불활성화 백신
    1.
    发明公开

    公开(公告)号:KR1020130012461A

    公开(公告)日:2013-02-04

    申请号:KR1020110073695

    申请日:2011-07-25

    Abstract: PURPOSE: A combined inactivated vaccine for preventing cellular diseases of fish using Streptococcus parauberis FPA4164 strain(KCTC 11980BP) is provided to effectively and cheaply prevent diseases caused by three kinds of bacteria. CONSTITUTION: An alpha-hemolytic Streptococcus parauberis FPA4164 strain(KCTC 11980BP) is isolated from flatfish. A combined inactivated vaccine for preventing cellular diseases of fish contains inactivated alpha-hemolytic Streptococcus parauberis FPA4164(KCTC 11980BP) antigen, inactivated beta-hemolytic Streptococcus iniae FP50249(KCTC 11634BP) antigen, and inactivated beta-hemolytic Edwardsiella tarda FP2018(KCTC 11145BP) antigen in a ratio of 1:1:1. The vaccine contains a montanide adjuvant. The adjuvant is montanide ISA35 or Gel01.

    Abstract translation: 目的:提供用于使用链脲霉素FPA4164菌株(KCTC 11980BP)预防鱼类细胞病的组合灭活疫苗,以有效和廉价地预防由三种细菌引起的疾病。 构成:从鲽鱼中分离出α-溶血性链脲霉素FPA4164株(KCTC 11980BP)。 用于预防鱼细胞疾病的组合灭活疫苗包含失活的α-溶血性链脲霉素FPA4164(KCTC 11980BP)抗原,灭活的β-溶血性链球菌FP50249(KCTC 11634BP)抗原和灭活的β-溶血性Edwardsiella tarda FP2018(KCTC 11145BP)抗原 以1:1:1的比例。 该疫苗含有一种montanide佐剂。 佐剂是montanide ISA35或Gel01。

Patent Agency Ranking